Women's health innovation, Algeria
Algeria
Algeria has no visible dedicated femtech startup scene, so the women's-health picture is driven by public health and policy rather than private products. Maternal mortality has fallen to around 62 per 100,000, but screening gaps remain stark: most breast cancers are still found by self-examination and Algeria has not introduced HPV vaccination. A 2023-2027 national digital health strategy and a small but growing women-in-tech accelerator pipeline are the most plausible foundations for future femtech, though neither yet targets women's health specifically.
Maternal mortality ratio unfpa.org
Breast cancer, the most common cancer in Algerian women (46% of female malignancies) aacrjournals.org
Contraceptive prevalence rate, latest widely cited figure algeria.unfpa.org
Arab-region respondents (incl. Algeria) with no information before their first period unfpa.org
Recent developments
Coverage centres on cancer epidemiology and menstrual-health awareness rather than product launches, reflecting a public-health rather than commercial femtech landscape.
Policy and public health
Women's-health policy in Algeria runs through the health ministry, UNFPA cooperation and national cancer control, with digital health still at an early framework stage.
Women's-health and women-in-tech ecosystem
There is no identifiable Algeria-based femtech company; the nearest relevant infrastructure is a general startup and women-in-tech accelerator ecosystem plus UN and research actors working on women's health.
Research and evidence
Peer-reviewed studies and UN reports are the strongest evidence base for Algerian women's health, particularly on cancer, maternal mortality and menstrual awareness.
Recent developments
Policy and public health
Women's-health and women-in-tech ecosystem
Ecosystem by organisation type
UN Population Fund country office leading family planning, safe motherhood and comprehensive sexuality education work with the government. algeria.unfpa.org
MENA accelerator for female-founded post-MVP startups; eligibility explicitly includes Algeria-based companies with at least one female founder holding equity. menabytes.com
Source of national cancer-incidence data showing breast cancer as 46% of female malignancies with 13,161 new cases in 2022. aacrjournals.org
A domestic accelerator and incubator scene exists but is general-purpose; no women's-health vertical has emerged from it to date. sramanamitra.com
Research and evidence
Sources and references
Every figure and claim above links back to a public source. 13 references, updated 2026-08.